Could a coronavirus vaccine rehab the pharmaceutical industry's reputation despite drug price increases?

  • 📰 USATODAY
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 63%

Business News News

Business Business Latest News,Business Business Headlines

For years, the pharmaceutical industry has faced withering bipartisan criticism and a deteriorating reputation among the public for its role in driving up drug prices.

Pharma industry executives say the vaccine push shows how the industry is committed to using profits, which have been the target of much criticism, to support their pursuit of life-saving medications.

"There are certainly bright spots in the pharma sector in terms of innovation, hope and optimism — and certainly those three things would apply to the work that’s happening around COVID-19," Lash said."But if you look at the performance of Big Pharma and their behavior over the last decade, it paints a very dark picture of drug pricing in America."

Pharmaceutical executives say their pricing is justified due to the high cost of research and development that is now contributing to the pursuit of a vaccine for the coronavirus. He attributed much of the criticism over drug prices to"relatively few bad actors" responsible for sharp increases, including Shkreli, who was later imprisoned after being convicted on unrelated fraud charges, and Mylan.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Withering bipartisian criticism from elected officials who have taken millions in campaign contributions and enacted no significant legislation in this area. Yeah real withering.....

what a garbage run not taking yoir ahit

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 100. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Asian shares waver with coronavirus, corporate earnings in focusAsian stocks dithered on Wednesday as an increase in new coronavirus cases in some parts of the world cast doubts over the economic recovery while oil prices eased on oversupply fears. With the pandemic spiraling out of control in the United States the markets will crash.
Source: Reuters - 🏆 2. / 97 Read more »

Asian shares waver with coronavirus, focus turns to corporate earningsAsian stocks dithered on Wednesday as an increase in coronavirus cases in some parts of the world undermined prospects for a quick economic recovery while oil prices eased on oversupply fears.
Source: Reuters - 🏆 2. / 97 Read more »